Feedback / Questions
Alzumab (itolizumab) - Biocon, Equillium, Ono Pharma
https://www.businesswire.com/news/home/20231108064995/en/Equillium-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Corporate-and-Clinical-Updates
Nov 8, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next